This morning, the FDA released long-awaited rules requiring chain restaurants to post calorie counts. The rules appear considerably stiffer than most anticipated, and will cover
Yesterday I wrote that auto-renewal, as it’s currently conceived, has me worried. I must not be the only one, because a new strategy was proposed
I’ve heard that Twitter has been abuzz this week with pics of nasty school lunches. As if in response, JAMA Pediatrics has a study looking
Muthiah Vaduganathan and Vinay Prasad in a JAMA Viewpoint: From a pragmatic standpoint, drug development programs conducted in broad populations poorly prioritize which patients should start therapy first. If
Robert Langreth reports: Unless more is done about a wave of new and expensive drugs, some priced at as much as $50,000 a month, Miller
Paul Demko reports: [CMS] wants to require insurers to establish “pharmacy and therapeutics” committees that would meet at least four times a year to review drug
Pamela Hartzband and Jerome Groopman have a recent New York Times editorial arguing that quality incentives for doctors are corrupting medicine: [F]inancial forces largely hidden from the public are beginning
Work posted here under copyright © of the authors • Details on the Site Policies page
